Skip to main content
    S

    Surrozen Inc (SRZN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $32.32
    +0.71 (+2.25%)

    Market Cap: $602.54M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Surrozen Inc (SRZN) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Surrozen reported EPS of -$4.75, below the -$1.32 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    43%(9/21)
    Avg Surprise
    -56.83%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.95
    Range-$1.28 - -$0.64
    8 analysts
    Revenue Consensus
    $484.50K
    RangeN/A
    6 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$1.00
    Range-$1.03 - -$0.97
    2 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.86-16.3%
    60d ago-$0.87-15.6%
    30d ago-$0.87-15.6%
    7d ago-$0.87-15.6%
    Current-$1.00
    Revenue Consensus
    $500.00K
    RangeN/A
    2 analysts

    Next Report

    SRZN's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 21 quarters below that had an estimate, SRZN beat 9 and missed 12. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 826.61% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$4.75-$1.32-$1.33 - -$1.30-259.85%MissN/A30 up, 2 downNov 9, 2026N/A
    Jun 30, 2026-$0.41-$1.34N/A+69.40%BeatN/A20 up, 2 downAug 6, 2026$5.00M
    Mar 31, 2026-$4.63-$0.72-$0.72 - -$0.72-543.06%Miss-158.5%22 up, 0 downMay 6, 2026$5.00M
    Dec 31, 2025-$9.62-$1.24-$1.24 - -$1.23-678.79%MissN/A21 up, 0 downMar 23, 2026$528000
    Sep 30, 2025-$3.60-$1.17-$1.17 - -$1.17-207.69%MissN/A11 up, 0 downNov 7, 2025$983000
    Jun 30, 2025-$1.14-$1.23-$1.23 - -$1.23+7.32%BeatN/A10 up, 1 downAug 8, 2025$983000
    Mar 31, 2025$7.92-$1.09-$1.09 - -$1.09+826.61%BeatN/A11 up, 0 downMay 9, 2025$983000
    Dec 31, 2024-$9.09-$2.70N/A-236.67%MissN/A10 up, 1 downMar 31, 2025$655000
    Sep 30, 2024-$0.44-$2.77-$2.77 - -$2.16+84.12%BeatN/A20 up, 0 downNov 6, 2024$10.00M
    Jun 30, 2024-$7.99-$2.79-$2.79 - -$2.79-186.38%MissN/A10 up, 0 downAug 12, 2024N/A
    Mar 31, 2024-$4.24-$4.25-$4.25 - -$4.25+0.24%BeatN/A11 up, 0 downMay 8, 2024N/A
    Dec 31, 2023-$4.41-$3.00-$4.35 - -$1.65-47.00%MissN/A20 up, 0 downMar 27, 2024N/A
    Sep 30, 2023-$5.10-$4.20-$4.65 - -$4.20-21.43%MissN/A20 up, 0 downNov 8, 2023N/A
    Jun 30, 2023-$4.65-$6.00-$6.30 - -$6.00+22.50%BeatN/A20 up, 0 downAug 9, 2023N/A
    Mar 31, 2023-$7.20-$5.42-$5.85 - -$4.95-32.84%MissN/A30 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$0.03-$0.03N/A-4.60%MissN/A40 up, 0 downMar 22, 2023$12.50M
    Sep 30, 2022-$5.70-$6.43-$7.20 - -$5.85+11.35%BeatN/A40 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$6.00-$6.90N/A+13.04%BeatN/AN/A0 up, 0 downAug 11, 2022N/A
    Mar 31, 2022-$3.45-$8.10-$9.30 - -$6.45+57.41%BeatN/A30 up, 0 downMay 11, 2022N/A
    Dec 31, 2021-$0.60-$0.44-$0.52 - -$0.40-36.36%MissN/A3N/AMar 24, 2022N/A
    Sep 30, 2021-$7.65-$5.85-$5.85 - -$5.70-30.77%MissN/A3N/ANov 15, 2021N/A
    Jun 30, 2021-$0.38N/AN/AN/AN/AN/AN/AN/AJul 15, 2021N/A
    Mar 31, 2021-$0.31N/AN/AN/AN/AN/AN/AN/AMay 14, 2021N/A
    Dec 31, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/AJan 4, 2021N/A
    Last 24 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$6.44, after -$21.76 the year before. It was -$8.94 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years below with reported EPS.

    Fiscal year endedEPSChange
    Dec 31, 2025-$6.44N/A
    Dec 31, 2024-$21.76N/A
    Dec 31, 2023-$21.36N/A
    Dec 31, 2022-$15.18N/A
    Dec 31, 2021-$8.94N/A
    Dec 31, 2020Not reportedN/A

    Frequently Asked Questions About SRZN

    Did SRZN beat earnings estimates last quarter?

    No. Surrozen reported EPS of -$4.75 for the quarter ended Sep 30, 2026, below the -$1.32 estimate by 259.85%.

    What EPS do analysts expect from SRZN next quarter?

    The consensus EPS estimate for Surrozen for the quarter ending Dec 31, 2026 is -$0.95 from 8 analysts, with estimates from -$1.28 to -$0.64.

    How often does SRZN beat earnings estimates?

    Surrozen beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -127.84%.